🇺🇸 SRPT — Sarepta Therapeutics, Inc.

Salud Mantener
← Volver

Precio actual

18,54 USD

Máx. histórico

178,74

2142 días

Split 1:6 del 12/07/2012

Caída desde máximo

-89,63%

Rango 52 semanas

14,68 – 24,68

Variación hoy

+1,20%

Cierre anterior

18,32

Rango de hoy

18,29 – 18,81

Volumen hoy

1.397.929

Peor caída histórica

-98,17%

09/02/2000 → 18/12/2008

Recuperado en 3568 días

Volatilidad anualizada ⓘ

95,44%

Información
Nombre completo
Sarepta Therapeutics, Inc.
Divisa
USD
Mercado
NasdaqGS
Sector
Salud
Industria
Biotechnology
Empleados
835
PER ⓘ
—
Dividend yield
0,00% (puede no estar actualizado)
Precio objetivo analistas
21,64 USD (puede no estar actualizado)
Primera cotización
04/06/1997
Precio actualizado
hace 16 horas
Sobre la empresa

Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, siRNA platform, gene therapy, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 for the treatment of Duchenne in patients who have a confirmed mutation of the dystrophin gene that is amenable to exon 51 skipping; VYONDYS 53 for the treatment of Duchenne in patients who have a confirmed mutation of the dystrophin gene that is amenable to exon 53 skipping; AMONDYS 45 for the treatment of Duchenne in patients who have a confirmed mutation of the dystrophin gene that is amenable to exon 45 skipping; and ELEVIDYS, an AAV-based gene therapy, which is contraindicated in patients with any deletion in exon 8 and/or exon 9 in the Duchenne gene. The company also develops SRP-9003, a gene therapy program for the treatment of LGMD2E; SRP-1001 to selectively target and knockdown DUX4 using RNAi in Phase 1/2a clinical trials; and SRP-1003 for reduction of expression of the DMPK gene in Phase 1/2a clinical trials. It has collaboration and license agreements with F. Hoffman-La Roche Ltd; Arrowhead Pharmaceuticals, Inc.; University of Western Australia; Nationwide Children's Hospital; Hansa Biopharma; and Duke University. The company was incorporated in 1980 and is headquartered in Cambridge, Massachusetts.

Splits Registrados en el histórico de precios
Fecha Ratio
12/07/2012 1:6
Rentabilidad mensual
Evolución
Histórico día a día
Fecha Apertura Máximo Mínimo Cierre Variación Volatilidad día Volumen
10/05/2000 53,25 54,38 52,88 54,00 -0,69% 2,82% 14.567
09/05/2000 55,03 55,88 53,25 54,38 -2,36% 4,77% 68.517
08/05/2000 56,63 57,00 54,75 55,69 -1,66% 3,97% 5.867
05/05/2000 54,00 57,00 54,00 56,63 +4,14% 5,56% 5.733
04/05/2000 53,63 56,25 52,88 54,38 +0,69% 6,29% 5.733
03/05/2000 56,63 57,00 53,25 54,00 -1,37% 6,62% 27.850
02/05/2000 59,25 60,00 53,63 54,75 -9,32% 10,76% 11.367
01/05/2000 55,50 61,50 54,75 60,38 +9,52% 12,16% 14.583
28/04/2000 53,25 57,00 51,75 55,13 +7,69% 9,86% 10.133
27/04/2000 47,25 53,25 46,88 51,19 -5,21% 13,49% 11.750
26/04/2000 57,00 57,00 52,50 54,00 -7,10% 7,89% 9.133
25/04/2000 57,00 60,00 52,50 58,13 +1,97% 13,16% 11.117
24/04/2000 61,50 61,50 54,00 57,00 -5,00% 12,20% 11.550
20/04/2000 60,00 61,50 57,75 60,00 +1,27% 6,25% 8.850
19/04/2000 60,38 62,25 57,00 59,25 +0,00% 8,70% 22.833
18/04/2000 48,00 60,38 48,00 59,25 +22,48% 25,78% 41.617
17/04/2000 40,59 59,25 40,50 48,38 -9,15% 46,19% 56.033
14/04/2000 64,50 64,50 52,88 53,25 -19,32% 18,02% 45.150
13/04/2000 71,25 72,00 66,00 66,00 -11,11% 8,42% 16.500
12/04/2000 79,50 80,25 72,00 74,25 -7,48% 10,38% 13.567
11/04/2000 84,38 85,88 78,00 80,25 -7,76% 9,33% 23.117
10/04/2000 87,38 88,50 83,63 87,00 +2,65% 5,58% 20.367
07/04/2000 87,75 88,50 84,00 84,75 -0,88% 5,13% 21.083
06/04/2000 84,00 88,50 80,25 85,50 +13,43% 9,82% 46.233
05/04/2000 72,00 85,50 70,50 75,38 +5,79% 20,83% 64.967
04/04/2000 82,50 82,88 63,00 71,25 -7,77% 24,09% 35.917
03/04/2000 78,00 83,63 75,00 77,25 +3,00% 11,06% 27.150
31/03/2000 64,13 78,00 63,00 75,00 +13,64% 23,39% 67.300
30/03/2000 72,00 73,13 64,50 66,00 -10,66% 11,98% 26.950
29/03/2000 74,25 79,50 64,13 73,88 +0,51% 20,71% 95.233